StockWatch
·
Pharmaceuticals
Auditor13 May 2026, 01:19 pm

Cipla Appoints Joshi Apte & Associates as Cost Auditors

AI Summary

Cipla Ltd's Board of Directors, in its meeting held on May 13, 2026, approved the appointment of M/s Joshi Apte & Associates as Cost Auditors for the financial year 2026-27. The board also approved convening the 90th Annual General Meeting on June 25, 2026, and granted stock options and ESARs under the Cipla Employee Stock Option Scheme 2013-A and the Cipla Employee Stock Appreciation Rights Scheme 2021. Additionally, Mr. Sushrut Kulkarni was appointed as President & Global Chief – Integrated Product Development (IPD).

Key Highlights

  • M/s Joshi Apte & Associates appointed as Cost Auditors for FY 2026-27.
  • 90th Annual General Meeting scheduled for June 25, 2026.
  • Stock options and ESARs granted under employee schemes.
  • Sushrut Kulkarni appointed President & Global Chief – Integrated Product Development (IPD).